Antiplatelet agents are the mainstay treatment
in the prevention and management of atherothrombotic
complications. However, a substantial interpatient variability
in response to clopidogrel has been reported. ...
Objectives:
To perform a systematic review to provide rationale for intracoronary (IC) abciximab administration in
patients with ST-segment elevation myocardial infarction (STEMI), to summarize recent studies
comparing ...
